Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Measurement and Modeling of Peripherally Administered Anti-CGRP Monoclonal Antibody in CSF and Brain of Healthy Volunteers

Author:Rorabaugh, Jacki   Bryson, Juline   Hellriegel, Edward   Radivojevic, Andrijana   Dotan, Or   Ghibellini, Giulia   Zeng, Hang   Lu, Xiaofeng   Dai, Fangteng   Angeles, Thelma   Szilagy, Olga   Wang, James   Mallett, Steve   Barash, Steve   Rabinovich-Guilatt, Laura   Goadsby, Peter   Ahn, Andrew   

Session Name:S22: Advances in Migraine and Therapeutics  

Topic:Headache  

Program Number:S22.006  

Author Institution:Teva Pharmaceuticals, Denver, CO  Teva Pharmaceuticals, West Chester, PA  intiGROWTH LLC, Miami, FL  Teva Pharmaceuticals, Netanya, Israel  Teva Pharmaceuticals, Wayne, PA  Teva Pharmaceuticals, Debrecen, Hungary  University of California, Los Angeles, Los Angeles, CA  

Zavegepant Intranasal Spray for the Acute Treatment of Migraine: A Systematic Review and Meta-analysis of Randomized Clinical Trials

Author:Bardhan, Mainak   Suresh, Vinay   Dave, Tirth   Shamim, Muhammad Aaqib   Suresh, Dilip   Satish, Poorvikha   Dhakal, Bishal   Bhonsale, Aman   Roy, Priyanka   Monteith, Teshamae   

Session Name:S22: Advances in Migraine and Therapeutics  

Topic:Headache  

Program Number:S22.007  

Author Institution:Miami Cancer Institute,Baptist Health South Florida, Miami, FL  King George's Medical University, Lucknow, India  Bukovinian State Medical University, Chernivtsi, Ukraine  All India Institute of Medical Science - Jodhpur, Jodhpur, India  Madras Medical College, Chennai, India  St John’s Medical College, Bengaluru, India  Bardibas Field Hospital, Nepalese Army Institute of Health Sciences, Kathmandu, Nepal  All India Institute of Medical Sciences, Nagpur, Nagpur, India  Directorate of Factories, Department of Labour, Government of West Bengal, Kolkata, India  University of Miami, Millar school of Medicine, Miami, FL  

Long-term Maintenance of =50% Migraine Response with Eptinezumab Treatment in Patients with 2–4 Prior Preventive Migraine Treatment Failures

Author:Ailani, Jessica   Soni-Brahmbhatt, Seema   Awad, Susanne   Lee, Xin Ying   Sperling, Bjorn   Lipton, Richard B.   

Session Name:S22: Advances in Migraine and Therapeutics  

Topic:Headache  

Program Number:S22.008  

Author Institution:Georgetown University Hospital, Washington, DC  Lundbeck LLC, Deerfield, IL  H. Lundbeck A/S, Copenhagen, Denmark  Albert Einstein College of Medicine, Bronx, NY  

Vaporized Cannabis versus Placebo for Acute Migraine: A Randomized Controlled Trial

Author:Schuster, Nathaniel   Wallace, Mark   Buse, Dawn   Marcotte, Thomas   Lee, Euyhyun   Liu, Lin   Sexton, Michelle   

Session Name:S22: Advances in Migraine and Therapeutics  

Topic:Headache  

Program Number:S22.010  

Author Institution:UC San Diego, La Jolla, CA  Albert Einstein College of Medicine, Bronx, NY  UC San Diego, San Diego, CA  

Evidence-sharing Methods Utilized by Clinicians During Prognostication Meetings for Critically Ill Neurologic Patients

Author:Kotamreddy, Mahimasri   Honzel, Brooke   Carandang, Raphael   Muehlschlegel, Susanne   

Session Name:S23: Neurocritical Care  

Topic:Neurocritical Care  

Program Number:S23.001  

Author Institution:University of Massachusetts Chan Medical School, Framingham, MA  University of Massachusetts Chan Medical School, Worcester, MA  University of Massachusetts Medical School/UMASS Memorial Medical Group, Worcester, MA  Johns Hopkins School of Medicine, Baltimore, MD